Abstract
Objective: The aim of this study was to develop and validate simple and economical HPLC method for estimation of Teriflunomide in human plasma.
Methods: HPLC method was developed using AgilentEclipse XBD C8 (4.6 mm×150 mm) as stationary phase and mobile phase used was ammonium acetate buffer: methanol (40: 60 v/v). The detection was carried at wavelength 294 nm. A simple protein precipitation technique was used with acetonitrile as protein precipitating agent and Paliperidone palmitate was chosen as internal standard. Validation was carried out as per USFDA guidelines for bio-analytical method.
Results: The linearity range set was 10–60 μg/ml. The value of regression coefficient was found to be 0.9953. Retention time for Teriflunomide was found to be 4.8 min. The developed method was validated for various parameters such as specificity, linearity, accuracy, precision, recovery, and stability.
Conclusion: The developed method is simple, rapid, and economical for estimation of Teriflunomide in human plasma.
Publisher
Innovare Academic Sciences Pvt Ltd
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology
Reference13 articles.
1. PubChem. PubChem Compound Summary for CID 54684141, Teriflunomide. Bethesda: National Library of Medicine, US. National Center for Biotechnology Information; 2004. Available from: https:// www.pubchem.ncbi.nlm.nih.gov/compound/teriflunomide [Last accessed on 2022 Apr 24].
2. Parekh JM, Vaghela RN, Sutariya DK, Sanyal M, Yadav M, Shrivastav PS. Chromatographic separation and sensitive determination of teriflunomide, an active metabolite of leflunomide in human plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2010;878:2217-25. doi: 10.1016/j. jchromb.2010.06.028, PMID 20643586
3. Rakhila H, Rozek T, Hopkins A, Proudman S, Cleland L, James M, et al. Quantitation of total and free teriflunomide (A77 1726) in human plasma by LC-MS/MS. J Pharm Biomed Anal 2011;55:325-31. doi: 10.1016/j.jpba.2011.01.034, PMID 21349677
4. Rule GS, Rockwood AL, Johnson-Davis KL. LC-MS/MS method for the quantification of the leflunomide metabolite, teriflunomide. In: Langman LJ, Snozek CL, editors. Human Serum/Plasma. LC-MS in Drug Analysis-Part of Methods in Molecular Biology Book Series. Berlin: Springer; 2018. p. 75-83.
5. Yao X, Liu Y, Song L, Jiang J, Xiao F, Liu D, et al. Development of a simple HPLC-MS/MS method to simultaneously determine teriflunomide and its metabolite in human plasma and urine: Application to clinical pharmacokinetic study of teriflunomide sodium and leflunomide. Biomed Chromatogr 2018;33:e4420.